Skip to content Skip to footer

Canadian cannabis retailers reach new records in May as illicit market sales fall

Canadian cannabis retailers reach new records in May as illicit market sales fall
Share this story

July 24th, 2020

Arnau Valdovinos


 

A total of CAD$850 million worth of cannabis has now been sold in licensed dispensaries in the first 5 months of 2020, which means that, according to current projections, total sales are set to surpass the CAD$2 billion in 2020.

Since cannabis was legalised in Canada in October 2018, the contribution of legal cannabis to the country’s GDP (which takes into account domestic retail sales, investments, inventories and the balance of trade) has increased four-fold and currently represents 0.26% of Canada’s GDP, valued at CAD$4.3 billion.

This has come at the expense of illegal trade, which has been included in GDP estimates since 2017 to account for the effects of legalisation. The illicit market has plummeted 25% in the first 20 months of legalisation, slashing the policing and healthcare costs of prohibition, while hundreds of millions of dollars are being collected in excise duties, sales taxes and license fees.

At a provincial level, Alberta led the sales of legal cannabis in May 2020, with a quarter of all sales being produced in the Western province, despite it representing less than 12% of the Canadian population. This is mainly due to the liberal approach to cannabis retail implemented in the province, which is home to 497 dispensaries, despite some signs of overbuilding that has led to cost restructuring.

On the other hand, the largest province Ontario, home to 38% of the Canadian population, only accounted for 22% of sales in the last month of the period, following the slow approval process of new retail outlets. Ontario only counts with a 100 open storefronts, despite hundreds of pending applications.

Meanwhile, Quebec, where its public monopoly only possesses some 40 cannabis storefronts, represented 21% of sales. British Columbia accounted for 15% of sales in May 2020 while Saskatchewan accounted for 6% with the 8 other provinces and territories combined representing 11% of retail sales.

For more in-depth information, consumer data and strategic support, contact the Prohibition Partners consultancy team at info@prohibitionpartners.com or download one of our industry-leading reports.

Recent posts
October 16, 2024
Medical Cannabis Sales in Germany Expected to Reach €420 Million in 2024
January 31, 2024
New Reforms Set to Send Israeli Medical Cannabis Patient Numbers Soaring – Industry Growth to Follow
January 31, 2024
LAUNCHING TODAY | The Israeli Cannabis Report
January 23, 2024
LAUNCHING TODAY | Oceania Regulatory Report

Catch up on our newest articles that you might have missed

WEB_slider-German-report-02
October 16, 2024
Medical Cannabis Sales in Germany Expected to Reach €420 Million in 2024
Following the adoption of the CanG and the associated MedCanG Act, the German medical cannabis market is witnessing significant growth,...
israel cannabis reform
January 31, 2024
New Reforms Set to Send Israeli Medical Cannabis Patient Numbers Soaring – Industry Growth to Follow
The number of Israeli patients using medical cannabis is set to soar by 2027, as imminent reforms will make it...
Israel cannabis
January 31, 2024
LAUNCHING TODAY | The Israeli Cannabis Report
Prohibition Partners are proud to announce the publication of The Israeli Cannabis Report.  This report delves into the intricate journey...
WEB_slider-Oceania-report_2
January 23, 2024
LAUNCHING TODAY | Oceania Regulatory Report
Prohibition Partners are proud to announce the publication of the Oceania Regulatory Report today. This report provides a current regulatory...

Market Briefing Request

Please complete your details and a representative will be in contact

In Depth Analysis Session Request

Please complete your details and a representative will be in contact

Data Access Request

Please complete your details and a representative will be in contact